September 28, 2023 Epicrispr Biotechnologies to Present Preclinical Data at 28th International Annual Congress of the World Muscle Society
September 19, 2023 Epicrispr Biotechnologies to Present at Upcoming BMO Biopharma Spotlight Series Event
September 14, 2023 Epicrispr Biotechnologies Reports Discovery of Exceptionally Durable Gene Activators and Creation of Machine Learning Algorithm to Design New Activators
August 17, 2023 Epicrispr Biotechnologies Presents New Data on Epigenetic Editing Platform at CRISPR Frontiers Conference
June 16, 2023 Epicrispr Biotechnologies Presents Compelling Preclinical Data Supporting Clinical Initiation of EPI-321 for FSHD
May 23, 2023 Epicrispr Biotechnologies to Participate in a Fireside Chat at the Stifel Genetic Medicines Day 2023
May 19, 2023 Epicrispr Biotechnologies Presents Preclinical Data on EPI-321 for Facioscapulohumeral Muscular Dystrophy at ASGCT 26th Annual Meeting
May 4, 2023 Epicrispr Biotechnologies to Present Preclinical Data at American Society of Gene & Cell Therapy (ASGCT) 26th Annual Meeting
April 18, 2023 SOLVE FSHD Invests in Epicrispr Biotechnologies to Advance Potentially Curative Therapy
March 29, 2023 Epicrispr Biotechnologies to Participate in the Guggenheim Healthcare Talks – Genomic Medicines and Rare Disease Days
March 14, 2023 In Pivotal Demonstration, Epicrispr Biotechnologies Accomplishes Persistent Gene Activation with Single Administration
